{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:59:36Z","timestamp":1789343976131,"version":"build-2803163510"},"reference-count":163,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["D43TW001140"],"award-info":[{"award-number":["D43TW001140"]}]},{"name":"Horizon Europe Program","award":["101103306"],"award-info":[{"award-number":["101103306"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Neurocysticercosis is the most common helminthic parasitic disease affecting the human central nervous system and is pleomorphic in its presentation. It is frequently encountered in daily practice in most parts of the world, and also commonly seen in industrialized countries in immigrant populations. In the past decade, new treatment (combined anti-parasitic drugs, increased attention to reducing treatment-associated inflammation and damage, new surgical strategies), and diagnostic (more specific antigen and antibody detection concepts and tools, more sensitive magnetic resonance imaging sequences) approaches, new animal models, and data on control of transmission have emerged. Still, diagnostic challenges persist and treatment approaches for some types of disease may differ, affecting clinical practice. This review provides clinicians in endemic and non-endemic countries with a comprehensive and practical reference to understand the variabilities in clinical expression of the disease and the optimal diagnostic and treatment approaches.<\/jats:p>","DOI":"10.1371\/journal.pntd.0013937","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:34:27Z","timestamp":1771958067000},"page":"e0013937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Taenia solium neurocysticercosis: Its current epidemiological, diagnostic, therapeutic, and control landscapes"],"prefix":"10.1371","volume":"20","author":[{"given":"Javier A.","family":"Bustos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran T.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz M.","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabemba E.","family":"Mwape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedantam","family":"Rajshekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-6269","authenticated-orcid":true,"given":"Hector H.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for The Cysticercosis Working Group in Peru (CWGP)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"pntd.0013937.ref001","unstructured":"World Health Organization. Taeniasis\/cysticercosis 2022 [cited 20 Dec 2024]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/taeniasis-cysticercosis#:~:text=When%20cysts%20develop%20in%20the,seizures%20and%20can%20be%20fatal"},{"issue":"1","key":"pntd.0013937.ref002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40249-024-01252-x","article-title":"Global burden of zoonotic infectious diseases of poverty, 1990-2021","volume":"13","author":"C Lv","year":"2024","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"pntd.0013937.ref003","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00085-19","article-title":"Taenia solium cysticercosis and its impact in neurological disease","volume":"33","author":"HH Garcia","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"pntd.0013937.ref004","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy157","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"66","author":"AC White","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pntd.0013937.ref005","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/pathogens11101212","article-title":"Human neurocysticercosis: an overview","volume":"11","author":"OH Del Brutto","year":"2022","journal-title":"Pathogens"},{"issue":"1","key":"pntd.0013937.ref006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4269\/ajtmh.19-0436","article-title":"Natural history of treated subarachnoid neurocysticercosis","volume":"102","author":"TE Nash","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0013937.ref007","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4269\/ajtmh.20-1330","article-title":"Mortality in parenchymal and subarachnoid neurocysticercosis","volume":"105","author":"J Abanto","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013937.ref008","unstructured":"World Health Organization. WHO guidelines on management of Taenia solium neurocysticercosis. WHO Guidelines Approved by the Guidelines Review Committee. Geneva; 2021"},{"issue":"8","key":"pntd.0013937.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003972","article-title":"Prevalence of neurocysticercosis in people with epilepsy in the eastern province of Zambia","volume":"9","author":"KE Mwape","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013937.ref010","unstructured":"Evaluation IfHMa. Cysticercosis\u2014level 3 cause; 2021 [cited 20 Dec 2024]. Available from: https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-cysticercosis-level-3-disease"},{"key":"pntd.0013937.ref011","doi-asserted-by":"crossref","first-page":"107777","DOI":"10.1016\/j.actatropica.2025.107777","article-title":"Disease burden and economic losses associated with Taenia solium cysticercosis in pigs and humans in Nigeria","volume":"270","author":"PO Odeniran","year":"2025","journal-title":"Acta Trop"},{"issue":"12","key":"pntd.0013937.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013746","article-title":"The epidemiology and spatial distribution of Taenia solium taeniosis and cysticercosis in Kenya: the case of Busia County","volume":"19","author":"YG Zemedhun","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"pntd.0013937.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013776","article-title":"Prevalence and risk factors associated with Taenia solium cysticercosis in pigs in Oyam district, Uganda","volume":"19","author":"R Were","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013937.ref014","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2025.e00445","article-title":"Seroprevalence and risk factors of porcine cysticercosis in Mpwapwa district, eastern-Central Tanzania","volume":"30","author":"JD Maganira","year":"2025","journal-title":"Parasite Epidemiol Control"},{"issue":"12","key":"pntd.0013937.ref015","article-title":"Human cysticercosis in Southeastern C\u00f4te d\u2019Ivoire: seroprevalence and risk factors in two rural departments","volume":"5","author":"M-K Soumahoro","year":"2025","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"pntd.0013937.ref016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013083","article-title":"Cysticercosis and neurocysticercosis in people from Mocuba district, Zamb\u00e9zia province: a Mozambican community-based study","volume":"19","author":"J Mucavele","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"pntd.0013937.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011437","article-title":"Geostatistical analysis of active human cysticercosis: results of a large-scale study in 60 villages in Burkina Faso","volume":"17","author":"V Dermauw","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013937.ref018","doi-asserted-by":"crossref","first-page":"106984","DOI":"10.1016\/j.actatropica.2023.106984","article-title":"Monetary burden of neurocysticercosis on a hospitalized population in Muli County, China","volume":"246","author":"IA Mosley","year":"2023","journal-title":"Acta Trop"},{"issue":"6","key":"pntd.0013937.ref019","first-page":"633","article-title":"Prevalence of taeniasis and sero\u2014prevalence of anti\u2014cysticercus antibody among residents in Tibetan agricultural areas of Sichuan Province","volume":"35","author":"X Chen","year":"2024","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"9","key":"pntd.0013937.ref020","first-page":"1964","article-title":"Molecular confirmation of Taenia solium taeniasis in child, timor-leste","volume":"30","author":"H Jin","year":"2024","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"pntd.0013937.ref021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/tmi.70001","article-title":"Risk factors for Taenia solium taeniasis: a case-control study in Lao PDR","volume":"30","author":"A Larkins","year":"2025","journal-title":"Trop Med Int Health"},{"issue":"4","key":"pntd.0013937.ref022","first-page":"109","article-title":"Diagnosis of neurocysticercosis in patients with epilepsy living in the south-western Dominican Republic","volume":"78","author":"D Rivera","year":"2024","journal-title":"Rev Neurol"},{"issue":"1","key":"pntd.0013937.ref023","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/20477724.2022.2083757","article-title":"Taenia solium taeniasis\/cysticercosis in Guatemala: a prevalent public health problem?","volume":"117","author":"RD Hern\u00e1ndez-Chea","year":"2023","journal-title":"Pathog Glob Health"},{"issue":"2","key":"pntd.0013937.ref024","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/epi4.12872","article-title":"Epilepsy and neurocysticercosis in rural areas of the Bolivian Chaco: what has changed during the last 30\u2009years?","volume":"9","author":"A Nicoletti","year":"2024","journal-title":"Epilepsia Open"},{"issue":"3","key":"pntd.0013937.ref025","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s44197-024-00271-z","article-title":"Neurocysticercosis prevalence and characteristics in communities of Sinda District in Zambia: a cross-sectional study","volume":"14","author":"G Zulu","year":"2024","journal-title":"J Epidemiol Glob Health"},{"issue":"8","key":"pntd.0013937.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010652","article-title":"Neurocysticercosis in Latin America: current epidemiological situation based on official statistics from four countries","volume":"16","author":"R Rodr\u00edguez-Rivas","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0013937.ref027","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa764","article-title":"Calcifications and the global burden of neurocysticercosis: not just rocks in your head","volume":"73","author":"AC White","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0013937.ref028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13071-019-3328-8","article-title":"Correction to: epidemiology of taeniosis\/cysticercosis in Europe, a systematic review: eastern Europe","volume":"12","author":"C Trevisan","year":"2019","journal-title":"Parasit Vectors"},{"key":"pntd.0013937.ref029","doi-asserted-by":"crossref","first-page":"1173909","DOI":"10.3389\/fneur.2023.1173909","article-title":"Neurocysticercosis in non-endemic regions: the experience of Qatar","volume":"14","author":"N Haddad","year":"2023","journal-title":"Front Neurol"},{"issue":"6","key":"pntd.0013937.ref030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/microorganisms9061221","article-title":"A large case series of neurocysticercosis in Kuwait, a nonendemic Arabian Gulf Country in the middle east region","volume":"9","author":"J Iqbal","year":"2021","journal-title":"Microorganisms"},{"issue":"3","key":"pntd.0013937.ref031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QCO.0000000000000831","article-title":"Neurocysticercosis: an update on diagnosis, treatment, and prevention","volume":"35","author":"R Pineda-Reyes","year":"2022","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"pntd.0013937.ref032","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/pathogens13110988","article-title":"Seroprevalence and risk factors for cysticercosis in Mexican Americans in Starr County, Texas","volume":"13","author":"MM Duffey","year":"2024","journal-title":"Pathogens"},{"issue":"11","key":"pntd.0013937.ref033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11908-017-0594-5","article-title":"Infections of the central nervous system in returning travelers and immigrants","volume":"19","author":"H Thompson","year":"2017","journal-title":"Curr Infect Dis Rep"},{"issue":"10","key":"pntd.0013937.ref034","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199209033271004","article-title":"Neurocysticercosis in an Orthodox Jewish community in New York City","volume":"327","author":"PM Schantz","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"pntd.0013937.ref035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4269\/ajtmh.1995.53.439","article-title":"Seroprevalence of cysticercosis in an Orthodox Jewish community","volume":"53","author":"AC Moore","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"10470","key":"pntd.0013937.ref036","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(24)02356-0","article-title":"Neurocysticercosis school outbreak in Belgium","volume":"404","author":"K Vanden Driessche","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"pntd.0013937.ref037","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1708-8305.2011.00592.x","article-title":"Neurocysticercosis among international travelers to disease-endemic areas","volume":"19","author":"OH Del Brutto","year":"2012","journal-title":"J Travel Med"},{"key":"pntd.0013937.ref038","unstructured":"ReportLinker. Global Pork Market is expected to be US$ 418.37 Billion by 2028; 2023 [cited 2024 Dec 20]. Available from: https:\/\/finance.yahoo.com\/news\/global-pork-market-expected-us-171000247.html?guccounter=1"},{"key":"pntd.0013937.ref039","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.apar.2021.03.003","article-title":"Taenia solium taeniasis\/cysticercosis: from parasite biology and immunology to diagnosis and control","volume":"112","author":"MA Dixon","year":"2021","journal-title":"Adv Parasitol"},{"issue":"12","key":"pntd.0013937.ref040","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"HH Garcia","year":"2014","journal-title":"Lancet Neurol"},{"issue":"9","key":"pntd.0013937.ref041","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3201\/eid2709.203349","article-title":"Geographically targeted interventions versus mass drug administration to control Taenia solium cysticercosis, Peru","volume":"27","author":"SE O\u2019Neal","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"pntd.0013937.ref042","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/cei.12709","article-title":"Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis","volume":"183","author":"A Arce-Sillas","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"pntd.0013937.ref043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008005","article-title":"Host immune responses during Taenia solium neurocysticercosis infection and treatment","volume":"14","author":"UF Prodjinotho","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0013937.ref044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004143","article-title":"A comparative study of peripheral immune responses to Taenia solium in individuals with parenchymal and subarachnoid neurocysticercosis","volume":"9","author":"I Tuero","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013937.ref045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.yebeh.2017.10.042","article-title":"Cognitive impairment and quality of life of people with epilepsy and neurocysticercosis in Zambia","volume":"80","author":"AL Nau","year":"2018","journal-title":"Epilepsy Behav"},{"key":"pntd.0013937.ref046","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.seizure.2023.04.005","article-title":"Neurocysticercosis-related seizures: imaging biomarkers","volume":"108","author":"C Ratcliffe","year":"2023","journal-title":"Seizure"},{"key":"pntd.0013937.ref047","doi-asserted-by":"crossref","first-page":"107139","DOI":"10.1016\/j.clineuro.2022.107139","article-title":"An update on neurocysticercosis-related epilepsy","volume":"213","author":"PH Espino","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"pntd.0013937.ref048","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/pathogens13010026","article-title":"Calcified neurocysticercosis: demographic, clinical, and radiological characteristics of a large hospital-based patient cohort","volume":"13","author":"JA Bustos","year":"2023","journal-title":"Pathogens"},{"issue":"12","key":"pntd.0013937.ref049","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14787210.2024.2409404","article-title":"Management of calcified cysticerci in the brain parenchyma: treating the dead parasite","volume":"22","author":"OH Del Brutto","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"pntd.0013937.ref050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005115","article-title":"Clinical symptoms, imaging features and cyst distribution in the cerebrospinal fluid compartments in patients with extraparenchymal neurocysticercosis","volume":"10","author":"R Bazan","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0013937.ref051","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/trstmh\/traa174","article-title":"Natural history of extraparenchymal neurocysticercosis","volume":"115","author":"I Murrieta","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"pntd.0013937.ref052","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4269\/ajtmh.22-0791","article-title":"Older age in subarachnoid neurocysticercosis reflects a long prepatent period","volume":"108","author":"F Nateros","year":"2023","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0013937.ref053","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17460913.2025.2472594","article-title":"Repair capacity of Taenia solium extraparenchymal cysts: radiological and in vitro evidence","volume":"20","author":"A Toledo","year":"2025","journal-title":"Future Microbiol"},{"issue":"10","key":"pntd.0013937.ref054","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/17460913.2025.2516413","article-title":"In vitro system for Taenia solium cysts culture and growth: progress toward a neurocysticercosis model","volume":"20","author":"MA Orrego","year":"2025","journal-title":"Future Microbiol"},{"issue":"12","key":"pntd.0013937.ref055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001435","article-title":"Identification of loci controlling restriction of parasite growth in experimental Taenia crassiceps cysticercosis","volume":"5","author":"R Ramirez-Aquino","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0013937.ref056","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinte.1985.00360030074016","article-title":"Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases","volume":"145","author":"J Sotelo","year":"1985","journal-title":"Arch Intern Med"},{"key":"pntd.0013937.ref057","first-page":"799","article-title":"Neurocysticercosis: concepts and controversies.","volume-title":"Medicine update","author":"S. Venkataraman","year":"1995"},{"issue":"9383","key":"pntd.0013937.ref058","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(03)14117-7","article-title":"Taenia solium cysticercosis","volume":"362","author":"HH Garc\u00eda","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"pntd.0013937.ref059","first-page":"343","article-title":"Genetic diversity of Taenia solium and its relation to clinical presentation of cysticercosis","volume":"94","author":"A Ito","year":"2021","journal-title":"Yale J Biol Med"},{"issue":"1","key":"pntd.0013937.ref060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00381-025-06937-8","article-title":"Comprehensive analysis of clinical, radiological profiles, diagnosis, treatment, and follow-up outcomes in pediatric neurocysticercosis patients: a retrospective observational study","volume":"41","author":"PN Patil","year":"2025","journal-title":"Childs Nerv Syst"},{"key":"pntd.0013937.ref061","first-page":"53","article-title":"The syndromic classification of the international league against epilepsy: a hospital based study from South India.","volume-title":"Progress in neurology","author":"JMK Murthy","year":"1995"},{"issue":"8","key":"pntd.0013937.ref062","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jnnp.54.8.702","article-title":"Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations","volume":"54","author":"MJ Chandy","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8634","key":"pntd.0013937.ref063","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(89)91771-6","article-title":"Cysticercosis causing single, small CT lesions in Indian patients with seizures","volume":"1","author":"MJ Chandy","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"pntd.0013937.ref064","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1600-0404.2000.102001044.x","article-title":"Severe episodic headache as the sole presenting ictal event in patients with a solitary cysticercus granuloma","volume":"102","author":"V Rajshekhar","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"pntd.0013937.ref065","doi-asserted-by":"crossref","first-page":"117527","DOI":"10.1016\/j.jns.2021.117527","article-title":"Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world","volume":"427","author":"J Bustos","year":"2021","journal-title":"J Neurol Sci"},{"key":"pntd.0013937.ref066","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.943133","article-title":"Neurocysticercosis presenting as migraine in the United States","volume":"25","author":"E Byrnes","year":"2024","journal-title":"Am J Case Rep"},{"issue":"4","key":"pntd.0013937.ref067","article-title":"Parental refusal to lumbar puncture: effects on treatment, hospital stay and leave against medical advice","volume":"12","author":"M Ahmed","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"pntd.0013937.ref068","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4269\/ajtmh.20-0509","article-title":"Lumbar puncture-related knowledge, attitudes, and practices among patients, caregivers, doctors, and nurses in Zambia","volume":"104","author":"MA Elafros","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0013937.ref069","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nic.2024.08.020","article-title":"Alternative percutaneous dural puncture routes: cervical, thoracic, lumbar, and sacral","volume":"35","author":"TF Massoud","year":"2025","journal-title":"Neuroimaging Clin N Am"},{"key":"pntd.0013937.ref070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2016.11.045","article-title":"Revised diagnostic criteria for neurocysticercosis","volume":"372","author":"OH Del Brutto","year":"2017","journal-title":"J Neurol Sci"},{"issue":"4","key":"pntd.0013937.ref071","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11604-016-0528-4","article-title":"A comprehensive review of imaging findings in human cysticercosis","volume":"34","author":"B Venkat","year":"2016","journal-title":"Jpn J Radiol"},{"issue":"3","key":"pntd.0013937.ref072","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s10072-021-05510-w","article-title":"How to look for intracranial calcification in children with neurological disorders: CT, MRI, or both of them?","volume":"43","author":"D Tonduti","year":"2022","journal-title":"Neurol Sci"},{"key":"pntd.0013937.ref073","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/0004-282x-anp-2022-s115","article-title":"Update on the diagnosis and management of neurocysticercosis","volume":"80","author":"OM Takayanagui","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"issue":"2","key":"pntd.0013937.ref074","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01550-21","article-title":"Improved diagnosis of viable parenchymal neurocysticercosis by combining antibody banding patterns on enzyme-linked immunoelectrotransfer blot (EITB) with Antigen Enzyme-linked immunosorbent assay (ELISA)","volume":"60","author":"G Arroyo","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"2","key":"pntd.0013937.ref075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/trstmh\/trab091","article-title":"Imaging correlates of serum enzyme-linked immunoelectrotransfer blot (EITB) positivity in patients with parenchymal neurocysticercosis: results from 521 patients","volume":"116","author":"P Vasudevan","year":"2022","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"pntd.0013937.ref076","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00424-18","article-title":"Laboratory diagnosis of neurocysticercosis (Taenia solium)","volume":"56","author":"HH Garcia","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"3","key":"pntd.0013937.ref077","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4269\/ajtmh.18-0697","article-title":"Performance of a sandwich antigen-detection ELISA for the diagnosis of porcine Taenia solium cysticercosis","volume":"100","author":"JA Bustos","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"pntd.0013937.ref078","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s00436-019-06425-4","article-title":"Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico","volume":"118","author":"M Hern\u00e1ndez","year":"2019","journal-title":"Parasitol Res"},{"issue":"6","key":"pntd.0013937.ref079","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0035-9203(00)90228-1","article-title":"Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients","volume":"94","author":"HH Garcia","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"pntd.0013937.ref080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010442","article-title":"A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis","volume":"16","author":"M Corda","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pntd.0013937.ref081","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0020-7519(92)90148-E","article-title":"A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis","volume":"22","author":"JR Brandt","year":"1992","journal-title":"Int J Parasitol"},{"issue":"4","key":"pntd.0013937.ref082","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-3024.1989.tb00673.x","article-title":"Specific detection of circulating surface\/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis","volume":"11","author":"LJ Harrison","year":"1989","journal-title":"Parasite Immunol"},{"key":"pntd.0013937.ref083","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exppara.2016.03.025","article-title":"Anti-Taenia solium monoclonal antibodies for the detection of parasite antigens in body fluids from patients with neurocysticercosis","volume":"166","author":"A Paredes","year":"2016","journal-title":"Exp Parasitol"},{"key":"pntd.0013937.ref084","doi-asserted-by":"crossref","first-page":"1394089","DOI":"10.3389\/fpara.2024.1394089","article-title":"From laboratory to clinical practice: an update of the immunological and molecular tools for neurocysticercosis diagnosis","volume":"3","author":"LM Toribio","year":"2024","journal-title":"Front Parasitol"},{"issue":"5","key":"pntd.0013937.ref085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00406-006-0612-3","article-title":"Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis","volume":"256","author":"CR Almeida","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"pntd.0013937.ref086","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4269\/ajtmh.18-0706","article-title":"Detection of Taenia solium DNA in the urine of neurocysticercosis patients","volume":"100","author":"L Toribio","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"pntd.0013937.ref087","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/cid\/ciz541","article-title":"A novel, highly sensitive quantitative polymerase chain reaction assay for the diagnosis of subarachnoid and ventricular neurocysticercosis and for assessing responses to treatment","volume":"70","author":"EM O\u2019Connell","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0013937.ref088","article-title":"Racemose neurocysticercosis: a case series","volume":"10","author":"S Sharma","year":"2024","journal-title":"BJR Case Rep"},{"issue":"4","key":"pntd.0013937.ref089","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4269\/ajtmh.2005.73.771","article-title":"Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats","volume":"73","author":"CM Scheel","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pntd.0013937.ref090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4269\/ajtmh.2011.10-0079","article-title":"Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA\u2122","volume":"84","author":"Y-M Lee","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0013937.ref091","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/JCM.03260-13","article-title":"Recombinant protein- and synthetic peptide-based immunoblot test for diagnosis of neurocysticercosis","volume":"52","author":"J Noh","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"1","key":"pntd.0013937.ref092","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13071-017-2160-2","article-title":"Comparison of T24H-his, GST-T24H and GST-Ts8B2 recombinant antigens in western blot, ELISA and multiplex bead-based assay for diagnosis of neurocysticercosis","volume":"10","author":"A Hernandez-Gonzalez","year":"2017","journal-title":"Parasit Vectors"},{"issue":"2","key":"pntd.0013937.ref093","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.17-0541","article-title":"Evaluating the recombinant T24H enzyme-linked immunoelectrotransfer blot assay for the diagnosis of neurocysticercosis in a panel of samples from a large community-based randomized control trial in 60 villages in Burkina Faso","volume":"98","author":"V Dermauw","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0013937.ref094","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1473-3099(23)00378-X","article-title":"Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study","volume":"24","author":"D Stelzle","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"pntd.0013937.ref095","doi-asserted-by":"crossref","first-page":"102893","DOI":"10.1016\/j.eclinm.2024.102893","article-title":"The performance of a point-of-care test for the diagnosis of Neurocysticercosis in a resource-poor community setting in Zambia\u2014a diagnostic accuracy study","volume":"77","author":"G Zulu","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"pntd.0013937.ref096","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CVI.00339-09","article-title":"Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis","volume":"17","author":"S Handali","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"pntd.0013937.ref097","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00760-23","article-title":"Multiantigen print immunoassay (MAPIA) for the diagnosis of neurocysticercosis: a single-center diagnostic optimization and accuracy study in Lima, Peru","volume":"61","author":"L Toribio","year":"2023","journal-title":"J Clin Microbiol"},{"issue":"7","key":"pntd.0013937.ref098","first-page":"1340","article-title":"Triplex ELISA for assessing durability of Taenia solium seropositivity after neurocysticercosis cure","volume":"29","author":"NL Tang","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pntd.0013937.ref099","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13071-020-04416-4","article-title":"Performance of Ag-ELISA in the diagnosis of Taenia solium cysticercosis in naturally infected pigs in Tanzania","volume":"13","author":"ML Kabululu","year":"2020","journal-title":"Parasit Vectors"},{"issue":"4","key":"pntd.0013937.ref100","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/pathogens12040566","article-title":"Consistent measurement of parasite-specific antigen levels in sera of patients with neurocysticercosis using two different monoclonal antibody (mAb)-based enzyme-linked immunosorbent assays","volume":"12","author":"Y Castillo","year":"2023","journal-title":"Pathogens"},{"key":"pntd.0013937.ref101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2013.09.005","article-title":"Development of specific scFv antibodies to detect neurocysticercosis antigens and potential applications in immunodiagnosis","volume":"156","author":"S Ribeiro V da","year":"2013","journal-title":"Immunol Lett"},{"issue":"3","key":"pntd.0013937.ref102","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4269\/ajtmh.20-0196","article-title":"Population screening for urine antigens to detect asymptomatic subarachnoid neurocysticercosis: a pilot study in northern Peru","volume":"103","author":"E McCleery","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pntd.0013937.ref103","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4269\/ajtmh.22-0598","article-title":"A rapid point-of-care assay for cysticercosis antigen detection in urine samples","volume":"108","author":"L Toribio","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013937.ref104","doi-asserted-by":"crossref","first-page":"116544","DOI":"10.1016\/j.jns.2019.116544","article-title":"Sorting out difficulties in immunological diagnosis of neurocysticercosis: development and assessment of real time loop mediated isothermal amplification of cysticercal DNA in blood","volume":"408","author":"G Goyal","year":"2020","journal-title":"J Neurol Sci"},{"issue":"5","key":"pntd.0013937.ref105","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4269\/ajtmh.23-0325","article-title":"Correlation between monocyte gene expression and inflammation on brain imaging in patients with solitary cerebral cysticercus granuloma","volume":"109","author":"BE Pamela","year":"2023","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0013937.ref106","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12879-018-3015-y","article-title":"Next generation sequencing based pathogen analysis in a patient with neurocysticercosis: a case report","volume":"18","author":"P Liu","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"5","key":"pntd.0013937.ref107","first-page":"603","article-title":"Report of a clinical case of cerebral cysticercosis treated medically with a new drug: praziquantel","volume":"21","author":"C Robles","year":"1979","journal-title":"Salud Publica Mex"},{"issue":"5","key":"pntd.0013937.ref108","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archneur.1988.00520290064015","article-title":"Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial","volume":"45","author":"J Sotelo","year":"1988","journal-title":"Arch Neurol"},{"issue":"3","key":"pntd.0013937.ref109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"HH Garcia","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"pntd.0013937.ref110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(14)70779-0","article-title":"Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial","volume":"14","author":"HH Garcia","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"pntd.0013937.ref111","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/trstmh\/trv078","article-title":"The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis","volume":"109","author":"ML Romo","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"18","key":"pntd.0013937.ref112","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1001\/archinte.1995.00430180088010","article-title":"Is the course of neurocysticercosis modified by treatment with antihelminthic agents?","volume":"155","author":"A Carpio","year":"1995","journal-title":"Arch Intern Med"},{"issue":"12","key":"pntd.0013937.ref113","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jocn.2006.09.004","article-title":"Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study","volume":"14","author":"K Das","year":"2007","journal-title":"J Clin Neurosci"},{"issue":"4","key":"pntd.0013937.ref114","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0035-9203(03)90075-7","article-title":"Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases","volume":"97","author":"S Gogia","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"pntd.0013937.ref115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/pathogens13030218","article-title":"Current role of surgery in the treatment of neurocysticercosis","volume":"13","author":"PT Hamamoto Filho","year":"2024","journal-title":"Pathogens"},{"key":"pntd.0013937.ref116","doi-asserted-by":"crossref","first-page":"108268","DOI":"10.1016\/j.clineuro.2024.108268","article-title":"A case-based review on the neuroendoscopic management of intraventricular and subarachnoid basal neurocysticercosis","volume":"240","author":"R De Marco","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"pntd.0013937.ref117","article-title":"Anthelmintics for people with neurocysticercosis","volume":"6","author":"EJM Monk","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"pntd.0013937.ref118","first-page":"187","article-title":"Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis","volume":"21","author":"D Guo","year":"2003","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"issue":"5","key":"pntd.0013937.ref119","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/INF.0b013e31819073aa","article-title":"Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial","volume":"28","author":"S Kaur","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"pntd.0013937.ref120","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/cid\/ciw134","article-title":"Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis","volume":"62","author":"HH Garcia","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pntd.0013937.ref121","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s15010-023-02021-y","article-title":"Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study","volume":"51","author":"D Stelzle","year":"2023","journal-title":"Infection"},{"issue":"1","key":"pntd.0013937.ref122","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.2011.03945.x","article-title":"Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis","volume":"72","author":"HH Garcia","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"pntd.0013937.ref123","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.4103\/jfmpc.jfmpc_733_23","article-title":"Albendazole and praziquantel combination versus albendazole alone in children with multiple neurocysticercosis: an open labelled randomized controlled trial","volume":"13","author":"V Rani","year":"2024","journal-title":"J Family Med Prim Care"},{"issue":"5","key":"pntd.0013937.ref124","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/08830738221077762","article-title":"Efficacy of combination therapy of albendazole and praziquantel vs albendazole monotherapy in children with persistent neurocysticercosis: a randomized controlled trial","volume":"37","author":"K Singh","year":"2022","journal-title":"J Child Neurol"},{"issue":"9","key":"pntd.0013937.ref125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s13312-021-2311-6","article-title":"Management of neurocysticercosis in children: association of child neurology consensus guidelines","volume":"58","author":"N Sankhyan","year":"2021","journal-title":"Indian Pediatr"},{"issue":"9","key":"pntd.0013937.ref126","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/epi.12739","article-title":"Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after","volume":"55","author":"HH Garcia","year":"2014","journal-title":"Epilepsia"},{"issue":"9","key":"pntd.0013937.ref127","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa784","article-title":"Frequency and determinant factors for calcification in neurocysticercosis","volume":"73","author":"JA Bustos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pntd.0013937.ref128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009193","article-title":"The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: a meta-analysis and expert group-based consensus recommendations","volume":"15","author":"A Abraham","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013937.ref129","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3389\/fimmu.2018.02652","article-title":"Human extraparenchymal neurocysticercosis: the control of inflammation favors the host\u2026but also the parasite","volume":"9","author":"A Toledo","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"pntd.0013937.ref130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/jnnp.62.6.659","article-title":"Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients","volume":"62","author":"OH Del Brutto","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"pntd.0013937.ref131","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1586\/ern.11.86","article-title":"Corticosteroid use in neurocysticercosis","volume":"11","author":"TE Nash","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"pntd.0013937.ref132","article-title":"Racemose neurocysticercosis presenting as vasculitic infarct and obstructive hydrocephalus: a rare presentation","volume":"17","author":"R Rawat","year":"2025","journal-title":"Cureus"},{"issue":"4","key":"pntd.0013937.ref133","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neurol.2025.02.003","article-title":"Racemose neurocysticercosis with meningitis and infectious vasculitis: a case report","volume":"181","author":"B Leger","year":"2025","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"pntd.0013937.ref134","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.18-0795","article-title":"Etanercept to control inflammation in the treatment of complicated neurocysticercosis","volume":"100","author":"TE Nash","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"pntd.0013937.ref135","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jix027","article-title":"Natural history of patients with perilesional edema around Taenia solium calcified granulomas","volume":"215","author":"TE Nash","year":"2017","journal-title":"J Infect Dis"},{"key":"pntd.0013937.ref136","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yebeh.2017.02.030","article-title":"Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy","volume":"76","author":"MM Bianchin","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"5","key":"pntd.0013937.ref137","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/02688699844691","article-title":"Endoscopic removal of a third ventricular cysticercal cyst","volume":"12","author":"SA Cudlip","year":"1998","journal-title":"Br J Neurosurg"},{"key":"pntd.0013937.ref138","doi-asserted-by":"crossref","first-page":"101872","DOI":"10.1016\/j.inat.2023.101872","article-title":"Multimodal minimally invasive surgery in the treatment of neurocysticercosis","volume":"36","author":"WW Lines-Aguilar","year":"2024","journal-title":"Interdiscip Neurosurg"},{"issue":"14","key":"pntd.0013937.ref139","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.0000000000207465","article-title":"Surgical debulking before medical management in a patient with massive racemose neurocysticercosis","volume":"101","author":"S Wahlster","year":"2023","journal-title":"Neurology"},{"key":"pntd.0013937.ref140","doi-asserted-by":"crossref","first-page":"1039083","DOI":"10.3389\/fnmol.2022.1039083","article-title":"New animal models of neurocysticercosis can help understand epileptogenesis in neuroinfection","volume":"15","author":"HH Garcia","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"pntd.0013937.ref141","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1017\/S0031182009991971","article-title":"Mesocestoides corti intracranial infection as a murine model for neurocysticercosis","volume":"137","author":"JI Alvarez","year":"2010","journal-title":"Parasitology"},{"issue":"3","key":"pntd.0013937.ref142","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S0031182015001572","article-title":"Cellular immune response in intraventricular experimental neurocysticercosis","volume":"143","author":"VBL Moura","year":"2016","journal-title":"Parasitology"},{"issue":"3","key":"pntd.0013937.ref143","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bpa.12669","article-title":"Axonal swellings and spheroids: a new insight into the pathology of neurocysticercosis","volume":"29","author":"A Mejia Maza","year":"2019","journal-title":"Brain Pathol"},{"issue":"8","key":"pntd.0013937.ref144","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.ajpath.2015.04.015","article-title":"Novel rat model for neurocysticercosis using Taenia solium","volume":"185","author":"MR Verastegui","year":"2015","journal-title":"Am J Pathol"},{"issue":"7","key":"pntd.0013937.ref145","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/brainsci13071021","article-title":"Standardizing an experimental murine model of extraparenchymal neurocysticercosis that immunologically resembles human infection","volume":"13","author":"A Espinosa-Cer\u00f3n","year":"2023","journal-title":"Brain Sci"},{"issue":"1","key":"pntd.0013937.ref146","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4269\/ajtmh.1997.56.33","article-title":"Immunotherapy for porcine cysticercosis: implications for prevention of human disease. Cysticercosis Working Group in Peru","volume":"56","author":"CA Evans","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pntd.0013937.ref147","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4269\/ajtmh.1996.54.391","article-title":"Effective, single-dose treatment or porcine cysticercosis with oxfendazole","volume":"54","author":"AE Gonzales","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013937.ref148","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-4017(95)00817-9","article-title":"Experimental Taenia solium cysticercosis in pigs: characteristics of the infection and antibody response","volume":"61","author":"AS de Aluja","year":"1996","journal-title":"Vet Parasitol"},{"issue":"10","key":"pntd.0013937.ref149","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijpara.2008.01.005","article-title":"Serological responses in porcine cysticercosis: a link with the parasitological outcome of infection","volume":"38","author":"N Deckers","year":"2008","journal-title":"Int J Parasitol"},{"issue":"1","key":"pntd.0013937.ref150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1645\/0022-3395(2002)088[0069:TEIOPW]2.0.CO;2","article-title":"The experimental infection of pigs with different numbers of Taenia solium eggs: immune response and efficiency of establishment","volume":"88","author":"E Santamar\u00eda","year":"2002","journal-title":"J Parasitol"},{"issue":"8","key":"pntd.0013937.ref151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003980","article-title":"Taenia solium: development of an experimental model of porcine neurocysticercosis","volume":"9","author":"A Fleury","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0013937.ref152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010449","article-title":"Porcine model of neurocysticercosis by intracarotid injection of Taenia solium oncospheres: dose assessment, infection outcomes and serological responses","volume":"16","author":"G Arroyo","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013937.ref153","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetpar.2016.02.025","article-title":"Severe seizures in pigs naturally infected with Taenia solium in Tanzania","volume":"220","author":"C Trevisan","year":"2016","journal-title":"Vet Parasitol"},{"issue":"5","key":"pntd.0013937.ref154","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/S0031182018001932","article-title":"Model systems for investigating disease processes in neurocysticercosis","volume":"146","author":"A de Lange","year":"2019","journal-title":"Parasitology"},{"issue":"7","key":"pntd.0013937.ref155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271232","article-title":"Experimental animal models and their use in understanding cysticercosis: a systematic review","volume":"17","author":"MC Sitali","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0013937.ref156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007301","article-title":"Strategies for tackling Taenia solium taeniosis\/cysticercosis: a systematic review and comparison of transmission models, including an assessment of the wider Taeniidae family transmission models","volume":"13","author":"MA Dixon","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0013937.ref157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008653","article-title":"Impact of a 3-year mass drug administration pilot project for taeniasis control in Madagascar","volume":"14","author":"NS Ramiandrasoa","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"24","key":"pntd.0013937.ref158","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1515520","article-title":"Elimination of Taenia solium transmission in northern Peru","volume":"374","author":"HH Garcia","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"pntd.0013937.ref159","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJMc1909955","article-title":"Evidence for potential elimination of active Taenia solium transmission in Africa?","volume":"383","author":"S Gabri\u00ebl","year":"2020","journal-title":"N Engl J Med"},{"key":"pntd.0013937.ref160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fvets.2019.00176","article-title":"Control of Taenia solium; a case for public and private sector investment","volume":"6","author":"LF Thomas","year":"2019","journal-title":"Front Vet Sci"},{"key":"pntd.0013937.ref161","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13071-015-0938-7","article-title":"Taenia solium taeniosis\/cysticercosis and the co-distribution with schistosomiasis in Africa","volume":"8","author":"UC Braae","year":"2015","journal-title":"Parasit Vectors"},{"key":"pntd.0013937.ref162","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1590\/S0004-282X1998000400010","article-title":"Neurocysticercosis: contribution of autopsies in the consolidation of mandatory notification in Ribeir\u00e4o Preto-SP,Brazil","volume":"56","author":"L Chimelli","year":"1998","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"pntd.0013937.ref163","first-page":"399","article-title":"A proposal to declare neurocysticercosis an international reportable disease","volume":"78","author":"G Rom\u00e1n","year":"2000","journal-title":"Bull World Health Organ"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:34:46Z","timestamp":1771958086000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013937"}},"subtitle":[],"editor":[{"given":"Marco","family":"Coral-Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":163,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013937","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}